22.10.2018
- French drugmaker Sanofi is planning to deepen the rare diseases footprint of its Genzyme franchise at Cambridge, Massachusetts, US, where according to reports the business could...
02.10.2018
- French drugmaker Sanofi has completed the divestment of its European generics business Zentiva to Advent International effective September 30. The transaction was finalized ahead...
17.09.2018
- In an unusual strategic use of human resources, European drugmakers Bayer and Sanofi are “swapping” pharmaceutical executives across continents. In one case, it is a return...
06.09.2018
- Two European drugmakers have had to deal with charges of misconduct in the US or from US authorities over the past week. A US-based research scientist with Glaxo Smith Kline...
06.08.2018
- The European Medicines Agency (EMA) is scaling back and suspending some activities as it loses more staff than initially anticipated in advance of its relocation from the UK to the...
12.07.2018
- French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...
18.04.2018
- French drugmaker Sanofi has confirmed market speculation that it is talking to Advent International about a sale of its European generics division, which trades as Zentiva. The...
17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
